Abstract
Context: The rate of ICD implantation of has grown substantially after results of primary and secondary prevention trials have demonstrated mortality superiority over pharmacologic therapy. Although transtelephonic monitoring is routine for pacemaker follow-up there is no systematically collected data supporting remote interrogation and monitoring (RIM) of ICD patients.
Objective: To prospectively measure the physician and patient acceptability, diagnostic value and safety of systematic periodic RIM of ICDS.
Methods: 124 patients with single chamber ICDs were monitored by remote RIM and by annual outpatient ICD analysis. Patients could initiate additional remote interrogations due to symptoms and physicians could increase the frequency of remote interrogations to monitor elective replacement indicators or if the device was identified as requiring more frequent follow-up. Outpatient clinic analysis was used to investigate abnormal remote interrogations. Main Outcome Measures: SF-36 and patient satisfaction surveys were obtained at baseline, at 3 and 6 months.
Results: 570 transmissions (5.1 + 2.4 per patient) were received and showed 54 delivered and 22 aborted ICD therapies and 30 episodes of NSVT. SF-36 results were no different at baseline, 3 and 6 months. Out of the total patients enrolled in the study, 93–99% of patients indicated complete or high satisfaction with remote interrogation in the five measures used to gauge satisfaction.
Conclusions: Remote ICD interrogation provides frequent, convenient, safe and comprehensive monitoring. Device and patient related problems were reliably detected and reduced the frequency of outpatient visits. Patients were highly satisfied with the convenience and ease of use of the system.
Similar content being viewed by others
References
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators.. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940.
A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.N Engl J Med 1997;337:1576-1583.
Bernstein AD, Parsonnet V. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997. Pacing Clin Electrophysiol 2001;24:842-855.
Seidl K, Senges J. Worldwide utilization of implantable cardioverter/ defibrillators now and in the future. Card Electrophysiol Rev 2003;7:5-13.
Wu LA, Kottke TE, Friedman PA, Luria DM, Grill DE, Maurer MJ. Implantable cardioverter defibrillator implantation rates in the Olmsted County, Minnesota, population: 1989–1999. J Clin Epidemiol 2002;55:458-461.
Morris MM, KenKnight BH, Warren JA, Lang DJ. A preview of implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach. Am J Cardiol 1999;83:48D-54D.
Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wikoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-2694.
Vallario LE, Leman RB, Gillette PC, Kratz JM. Pacemaker follow-up and adequacy of Medicare guidelines. Am Heart J 1988;116:11-5.
Anderson MH, Paul VE, Jones S, Ward DE, Camm AJ. Transtelephonic interrogation of the implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1992;15:1144-1150.
Theuns DA, Res JC, Jordaens LJ. Home monitoring in ICD therapy: Future perspectives. Europace 2003;5:139-142.
Letter to physicians from Ventritex regarding home monitoring of the Cadance (Model #100) Tiered Therapy Defibrillator System. 1991.
Sarter BH, Callans DJ, Gottlieb GD, Schwartzman DS, Marchlinski FE. Implantable defibrillator diagnostic storage capabilities: evolution, current status, and future utilization. Pacing Clin Electrophysiol 1998;21:1287-1298.
Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA 2001;286:793-799.
Maisel WH. Impact of expanding indications on the safety of pacemakers and defibrillators. Card Electrophysiol Rev 2003;7:30-32.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joseph, G.K., Wilkoff, B.L., Dresing, T. et al. Remote Interrogation and Monitoring of Implantable Cardioverter Defibrillators. J Interv Card Electrophysiol 11, 161–166 (2004). https://doi.org/10.1023/B:JICE.0000042356.52369.89
Issue Date:
DOI: https://doi.org/10.1023/B:JICE.0000042356.52369.89